Everyone from rock stars to nonagenarians experiences hearing loss, but no drugs have ever been approved specifically to prevent or treat this problem. Recently, a handful of drug companies have started to make some noise, with a number of experimental compounds now in human trials. Elie Dolgin sounds off on what could be a multibillion dollar market.
This is a preview of subscription content, log in via an institution to check access.
References
Rauch, S.D. et al. J. Am. Med. Assoc. 305, 2071–2079 (2011).
Lin, F.R., Niparko, J.K. & Ferrucci, L. Arch. Intern. Med. 171, 1851–1852 (2011).
Suckfuell, M., Canis, M., Strieth, S., Scherer, H. & Haisch, A. Acta Otolaryngol. 127, 938–942 (2007).
Ewert, D.L. et al. Hear. Res. 285, 29–39 (2012).
Lynch, E. & Kil, J. Semin. Hear. 30, 47–55 (2009).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. Sound medicine. Nat Med 18, 642–644 (2012). https://doi.org/10.1038/nm0512-642
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0512-642
- Springer Nature America, Inc.